keyword
https://read.qxmd.com/read/36977441/rabies-virus-glycoprotein-29-rvg29-promotes-car-t-immunotherapy-for-glioma
#21
JOURNAL ARTICLE
Feng Ji, Luxia Xu, Kaili Long, Fan Zhang, Miaomiao Zhang, Xiao Lu, Mingyue Xia, Jiannan Chen, Yu Du, Yong Tang, Heming Wu, Yan Shi, Ruiting Ma, Jun Li, Zhengliang Chen, Bin Xu, Qi Zhang, Junqing Liang, Shaochang Jia, Zhigang Hu, Zhigang Guo
Chimeric antigen receptor T cell (CAR-T) therapy has limited efficacy for treating glioma because of the infiltrative nature of the blood-brain barrier (BBB) and T cell exhaustion. Conjugation with rabies virus glycoprotein (RVG) 29 enhances the brain-related efficacy of various agents. Here we assess whether RVG enhances the ability of CAR-T cells to cross the BBB and improves their immunotherapy. We generated 70R CAR-T cells (anti-CD70 CAR-T modified with RVG29) and validated their tumor-killing efficacy in vitro and in vivo...
March 26, 2023: Translational Research: the Journal of Laboratory and Clinical Medicine
https://read.qxmd.com/read/36945572/glioblastoma-instructed-microglia-transit-to-heterogeneous-phenotypic-states-with-phagocytic-and-dendritic-cell-like-features-in-patient-tumors-and-patient-derived-orthotopic-xenografts
#22
Yahaya A Yabo, Pilar M Moreno-Sanchez, Yolanda Pires-Afonso, Tony Kaoma, Dimitrios Kyriakis, Kamil Grzyb, Suresh K Poovathingal, Aurélie Poli, Andrea Scafidi, Arnaud Muller, Reka Toth, Anaïs Oudin, Barbara Klink, Guy Berchem, Christophe Berthold, Frank Hertel, Michel Mittelbronn, Dieter H Heiland, Alexander Skupin, Petr V Nazarov, Simone P Niclou, Alessandro Michelucci, Anna Golebiewska
BACKGROUND: Glioblastoma (GBM) evades the immune system by creating an immune-suppressive tumor microenvironment (TME), where GBM-associated myeloid cells are geared towards tumor-supportive roles. However, it is unclear whether recruited myeloid cells are phenotypically and functionally identical. Here, we aim to understand the TME heterogeneity in GBM patients recapitulated in patient-derived orthotopic xenografts (PDOXs) and systematically characterize myeloid cell type identities at the molecular and functional level...
March 6, 2023: bioRxiv
https://read.qxmd.com/read/36937401/-in-vivo-loss-of-tumorigenicity-in-a-patient-derived-orthotopic-xenograft-mouse-model-of-ependymoma
#23
JOURNAL ARTICLE
Jacqueline P Whitehouse, Hilary Hii, Chelsea Mayoh, Marie Wong, Pamela Ajuyah, Paulette Barahona, Louise Cui, Hetal Dholaria, Christine L White, Molly K Buntine, Jacob Byrne, Keteryne Rodrigues da Silva, Meegan Howlett, Emily J Girard, Maria Tsoli, David S Ziegler, Jason M Dyke, Sharon Lee, Paul G Ekert, Mark J Cowley, Nicholas G Gottardo, Raelene Endersby
INTRODUCTION: Ependymomas (EPN) are the third most common malignant brain cancer in children. Treatment strategies for pediatric EPN have remained unchanged over recent decades, with 10-year survival rates stagnating at just 67% for children aged 0-14 years. Moreover, a proportion of patients who survive treatment often suffer long-term neurological side effects as a result of therapy. It is evident that there is a need for safer, more effective treatments for pediatric EPN patients. There are ten distinct subgroups of EPN, each with their own molecular and prognostic features...
2023: Frontiers in Oncology
https://read.qxmd.com/read/36838945/understanding-of-active-sites-and-interconversion-of-pd-and-pdo-during-ch-4-oxidation
#24
JOURNAL ARTICLE
Dong Gun Oh, Hristiyan A Aleksandrov, Haneul Kim, Iskra Z Koleva, Konstantin Khivantsev, Georgi N Vayssilov, Ja Hun Kwak
Pd-based catalysts are widely used in the oxidation of CH4 and have a significant impact on global warming. However, understanding their active sites remains controversial, because interconversion between Pd and PdO occurs consecutively during the reaction. Understanding the intrinsic active sites under reaction conditions is critical for developing highly active and selective catalysts. In this study, we demonstrated that partially oxidized palladium (PdOx ) on the surface plays an important role for CH4 oxidation...
February 18, 2023: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/36623346/synergistic-effects-of-concurrent-photodynamic-therapy-with-indocyanine-green-and-chemotherapy-in-hepatocellular-carcinoma-cell-lines-and-mouse-models
#25
JOURNAL ARTICLE
Jae Sun Park, Sohyun Park, Sang-Jae Park, Seok-Ki Kim
BACKGROUND: Photodynamic therapy (PDT) using an 808 nm laser irradiation with indocyanine green (ICG) has shown tumoricidal effects in a hepatocellular (HCC) orthotopic xenograft model. Recently, combining PDT with concurrent chemotherapy has shown synergistic outcomes and a better therapeutic effect for cancer treatment. In the present study, we utilized a combination of chemotherapy drugs and PDT using ICG in vitro and in vivo in a patient-derived orthotopic xenograft (PDoX) model...
December 29, 2022: Journal of Photochemistry and Photobiology. B, Biology
https://read.qxmd.com/read/36464844/probing-the-biocompatibility-and-immune-cell-association-of-chiral-water-soluble-bottlebrush-poly-2-oxazoline-s
#26
JOURNAL ARTICLE
David Pizzi, James Humphries, Joshua P Morrow, Ayaat M Mahmoud, Nicholas L Fletcher, Stefan E Sonderegger, Craig A Bell, Kristofer J Thurecht, Kristian Kempe
Poly(2-oxazoline)s (POx) have received substantial attention as poly(ethylene glycol) (PEG) alternatives in the biomedical field due to their biocompatibility, high functionality, and ease of synthesis. While POx have demonstrated strong potential as biomaterial constituents, the larger family of poly(cyclic imino ether)s (PCIE) to which POx belongs remains widely underexplored. One highly interesting sub-class of PCIE is poly(2,4-disubstituted-2-oxazoline)s (PdOx), which bear an additional substituent on the backbone of the polymers' repeating units...
December 4, 2022: Biomacromolecules
https://read.qxmd.com/read/36456116/elimination-of-axillary-lymph-node-metastases-in-a-patient-with-invasive-lobular-breast-cancer-treated-by-first-line-neo-adjuvant-chemotherapy-combined-with-methionine-restriction
#27
JOURNAL ARTICLE
Yutaro Kubota, Qinghong Han, Noriyuki Masaki, Chihiro Hozumi, Kazuyuki Hamada, Yusuke Aoki, Koya Obara, Takuya Tsunoda, Robert M Hoffman
BACKGROUND/AIM: Invasive lobular carcinoma (ILC) of the breast has a low complete-response rate in the neoadjuvant-chemotherapy setting. The addiction to methionine is a fundamental and ubiquitous characteristic of cancer cells, termed the Hoffman effect. We have previously targeted methionine addiction of breast cancer with recombinant methioninase (rMETase) using patient-derived orthotopic xenograft (PDOX) models. The aim of the present study was to determine the efficacy of methionine restriction with rMETase and a low-methionine diet combined with first-line neo-adjuvant chemotherapy, in a patient with metastatic ILC of the breast...
December 2022: Anticancer Research
https://read.qxmd.com/read/36409196/oxidative-stress-induced-fak-activation-contributes-to-uterine-serous-carcinoma-aggressiveness
#28
JOURNAL ARTICLE
Isabel C Lopez-Mejia, Jordi Pijuan, Raúl Navaridas, Maria Santacana, Sònia Gatius, Ana Velasco, Gerard Castellà, Anaïs Panosa, Elisa Cabiscol, Miquel Pinyol, Laura Coll, Núria Bonifaci, Laura Plata Peña, August Vidal, Alberto Villanueva, Eloi Gari, David Llobet-Navàs, Lluis Fajas, Xavier Matias-Guiu, Andrée Yeramian
Uterine serous carcinoma (USC) is an aggressive form of endometrial cancer (EC), characterized by its high propensity for metastases. In fact, while endometrioid endometrial carcinoma (EEC), which accounts for 85% of EC, presents a good prognosis, USC is the most frequently fatal. Herein, we used for the first time a peptide-based tyrosine-kinase-activity profiling approach to quantify the changes in tyrosine kinase activation between USC and EEC. Among the tyrosine kinases highly activated in USC, we identified focal adhesion kinase (FAK)...
January 2023: Molecular Oncology
https://read.qxmd.com/read/36373729/generation-and-integrated-analysis-of-advanced-patient-derived-orthoxenograft-models-pdox-for-the-rational-assessment-of-targeted-therapies-in-endometrial-cancer
#29
JOURNAL ARTICLE
Laura Devis-Jauregui, August Vidal, Laura Plata-Peña, Maria Santacana, Sandra García-Mulero, Nuria Bonifaci, Eulàlia Noguera-Delgado, Nuria Ruiz, Marta Gil, Eduard Dorca, Francisco J Llobet, Laura Coll-Iglesias, Katja Gassner, Maria Martinez-Iniesta, Ruth Rodriguez-Barrueco, Marc Barahona, Lola Marti, Francesc Viñals, Jordi Ponce, Rebeca Sanz-Pamplona, Josep M Piulats, Ana Vivancos, Xavier Matias-Guiu, Alberto Villanueva, David Llobet-Navas
Clinical management of endometrial cancer (EC) is handicapped by the limited availability of second line treatments and bona fide molecular biomarkers to predict recurrence. These limitations have hampered the treatment of these patients, whose survival rates have not improved over the last four decades. The advent of coordinated studies such as The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma (TCGA_UCEC) has partially solved this issue, but the lack of proper experimental systems still represents a bottleneck that precludes translational studies from successful clinical testing in EC patients...
November 14, 2022: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/36309387/chloroquine-combined-with-rapamycin-arrests-tumor-growth-in-a-patient-derived-orthotopic-xenograft-pdox-mouse-model-of-dedifferentiated-liposarcoma
#30
JOURNAL ARTICLE
Noriyuki Masaki, Yusuke Aoki, Yutaro Kubota, Koya Obara, Jun Miyazaki, Robert M Hoffman
BACKGROUND/AIM: Dedifferentiated liposarcoma (DDLS) is a type of soft-tissue sarcoma with a poor prognosis due to distant metastasis and resistance to chemotherapy. The antimalarial drug chloroquine (CQ) can induce apoptosis in cancer cells. CQ in combination with rapamycin (RAPA), an mTOR inhibitor, has shown efficacy on osteosarcoma and other types of cancer. In the present study the efficacy of RAPA combined with CQ on the treatment of a DDLS patient-derived orthotopic xenograft (PDOX) model was investigated...
November 2022: In Vivo
https://read.qxmd.com/read/36309364/oral-recombinant-methioninase-lowers-the-effective-dose-and-eliminates-toxicity-of-cisplatinum-for-primary-osteosarcoma-of-the-mammary-gland-in-a-patient-derived-orthotopic-xenograft-mouse-model
#31
JOURNAL ARTICLE
Noriyuki Masaki, Qinghong Han, Nathaniel F Wu, Carissa Samonte, Justin Wu, Chihiro Hozumi, Koya Obara, Yutaro Kubota, Yusuke Aoki, Jun Miyazaki, Robert M Hoffman
BACKGROUND/AIM: Primary osteosarcoma of the mammary gland is a very rare disease, accounting for under 1% of all mammary gland malignancies. There is no established first-line treatment, and prognosis is poor compared to conventional breast cancer. We previously demonstrated the efficacy of cisplatinum and eribulin in a patient-derived orthotopic xenograft (PDOX) mouse model of primary breast osteosarcoma. However, these drugs show significant clinical toxicity. All cancers are addicted to methionine (Hoffman effect)...
November 2022: In Vivo
https://read.qxmd.com/read/36293329/tspo-pet-imaging-as-a-potent-non-invasive-biomarker-for-diffuse-intrinsic-pontine-glioma-in-a-patient-derived-orthotopic-rat-model
#32
JOURNAL ARTICLE
Céline Chevaleyre, Dimitri Kereselidze, Fabien Caillé, Nicolas Tournier, Nagore G Olaciregui, Alexandra Winkeler, Xavier Declèves, Benoit Jego, Salvatore Cisternino, Sylvain Auvity, Charles Truillet
Diffuse intrinsic pontine gliomas (DIPG), the first cause of cerebral pediatric cancer death, will greatly benefit from specific and non-invasive biomarkers for patient follow-up and monitoring of drug efficacy. Since biopsies are challenging for brain tumors, molecular imaging may be a technique of choice to target and follow tumor evolution. So far, MR remains the imaging technique of reference for DIPG, although it often fails to define the extent of tumors, an essential parameter for therapeutic efficacy assessment...
October 18, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/36288875/oral-recombinant-methioninase-in-combination-with-rapamycin-eradicates-osteosarcoma-of-the-breast-in-a-patient-derived-orthotopic-xenograft-mouse-model
#33
JOURNAL ARTICLE
Noriyuki Masaki, Qinghong Han, Carissa Samonte, Nathaniel F Wu, Chihiro Hozumi, Justin Wu, Koya Obara, Yutaro Kubota, Yusuke Aoki, Michael Bouvet, Robert M Hoffman
BACKGROUND/AIM: Primary osteosarcoma of the breast is a very rare malignancy that shares histological features with osteosarcoma. It is also highly sensitive to methionine restriction due to methionine addiction. We previously established a patient-derived orthotopic xenograft (PDOX) nude-mouse model derived from tumor tissue of a patient with primary mammary osteosarcoma. In the present study, we investigated the efficacy of oral-recombinant methioninase (o-rMETase), combined with rapamycin, an inhibitor of mammalian target of rapamycin (mTOR) kinase, on a mammary osteosarcoma PDOX nude-mouse model...
November 2022: Anticancer Research
https://read.qxmd.com/read/36121505/patient-derived-intrafemoral-orthotopic-xenografts-of-peripheral-blood-or-bone-marrow-from-acute-myeloid-and-acute-lymphoblastic-leukemia-patients-clinical-characterization-methodology-and-validation
#34
JOURNAL ARTICLE
Jun Li, Hongkui Chen, ShiZhu Zhao, Danyi Wen, Lintao Bi
Acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) are malignant clonal diseases of the hematopoietic system with an unsatisfactory overall prognosis. The main obstacle is the increased resistance of AML and ALL cells to chemotherapy. The development and validation of new therapeutic strategies for acute leukemia require preclinical models that accurately recapitulate the genetic, pathological, and clinical features of acute leukemia. A patient-derived orthotopic xenograft (PDOX) model is established using surgical orthotopic implantation...
September 19, 2022: Clinical and Experimental Medicine
https://read.qxmd.com/read/36051919/the-application-of-68-ga-labeled-fapi-04-pet-ct-for-targeting-and-early-detection-of-pancreatic-carcinoma-in-patient-derived-orthotopic-xenograft-models
#35
JOURNAL ARTICLE
He Zhang, Jiaze An, Pengpeng Wu, Caiqin Zhang, Yong Zhao, Dengxu Tan, Changhong Shi, Xu Ge
[18 F]FDG as a probe of PET/CT is a radiolabeled glucose analogue taken up by most cells, but its batch activity is limited. [68 Ga]FAPI-04 is a promising alternative based on a fibroblast activation protein-specific inhibitor (FAPI) labeled with radiotracer FAP. Here, a series of databases suggested that FAP expression was significantly different in pancreatic cancer compared to normal tissue. The FAP-positive fibroblasts were evaluated around the tumor cells and the stroma. A patient-derived orthotopic xenograft (PDOX) model of pancreatic adenocarcinoma (PDAC) exhibits significantly higher quantitative uptake of [68 Ga]FAPI-04 ( P  < 0...
2022: Contrast Media & Molecular Imaging
https://read.qxmd.com/read/36041590/il-11r%C3%AE-targeted-nanostrategy-empowers-chemotherapy-of-relapsed-and-patient-derived-osteosarcoma
#36
JOURNAL ARTICLE
Jingjing Jiang, Renxian Wang, Liang Yang, Yongjie Sha, Songsong Zhao, Jianxun Guo, Dafu Chen, Zhiyuan Zhong, Fenghua Meng
Osteosarcoma (OS) is a rare but frequently lethal bone malignancy in children and adolescents. The adjuvant chemotherapy with doxorubicin (Dox) and cisplatin remains a mainstream clinical practice though it affords only limited clinical benefits due to low tumor deposition, dose-limiting toxicity and high rate of relapse/metastasis. Here, taking advantage of high IL-11Rα expression in the OS patients, we installed IL-11Rα specific peptide (sequence: cyclic CGRRAGGSC) onto redox-responsive polymersomes encapsulating Dox (IL11-PDox) to boost the specificity and anti-OS efficacy of chemotherapy...
August 31, 2022: Journal of Controlled Release
https://read.qxmd.com/read/36003796/review-precise-sarcoma-patient-derived-orthotopic-xenograft-pdox-mouse-models-enable-identification-of-novel-effective-combination-therapies-with-the-cyclin-dependent-kinase-inhibitor-palbociclib-a-strategy-for-clinical-application
#37
REVIEW
Takashi Higuchi, Kentaro Igarashi, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Michael Bouvet, Hiroyuki Tsuchiya, Robert M Hoffman
Introduction: Sarcomas are rare heterogeneous malignant tumors that originate and develop in soft tissue or bone. Effective treatment for sarcomas is still limited to traditional chemotherapy and surgery that are often ineffective for recurrent disease. Cyclin-dependent kinases (CDKs) promote abnormal cell cycling and cell division in many cancers including sarcomas. Therefore, our hypothesis was that CDK inhibitors may be useful candidates for sarcoma treatment. Patient-derived orthotopic xenograft (PDOX) mouse models mimic the clinical disease for all major cancer types and have identified effective treatments that hold much clinical promise...
2022: Frontiers in Oncology
https://read.qxmd.com/read/35763553/keys-unlocking-redispersion-of-reactive-pdo-x-nanoclusters-on-ce-functionalized-perovskite-oxides-for-methane-activation
#38
JOURNAL ARTICLE
Yanling Yang, Li Zhang, Hongquan Guo, Zhenfa Ding, Weitao Wang, Jianhui Li, Liujiang Zhou, Xin Tu, Yongfu Qiu, Gui Chen, Yifei Sun
Nowadays, trace CH4 emitted from vehicle exhausts severely threaten the balance of the ecology system of our earth. Thereby, the development of active and stable catalysts capable of methane conversion under mild conditions is critical. Here, we present a convenient method to redisperse catalytically inert PdO nanoparticles (NPs) (>10 nm) into reactive PdO x nanoclusters (∼2 nm) anchored on a Ce-doped LaFeO3 parent. Isothermally activated in an N2 flow, the redispersed catalyst achieved a CH4 conversion of 90% at 400 °C, which is significantly higher than the fresh and H2 - and O2 -treated counterparts (625, 616, and 641 °C, respectively), indicating the importance of the gas atmosphere in the redispersion of PdO NPs...
July 13, 2022: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/35761781/triple-negative-breast-cancer-drug-resistance-durable-efficacy-and-cure-how-advanced-biological-insights-and-emerging-drug-modalities-could-transform-progress
#39
JOURNAL ARTICLE
Ernestina Marianna De Francesco, Francesca Cirillo, Veronica Vella, Antonino Belfiore, Marcello Maggiolini, Rosamaria Lappano
INTRODUCTION: Triple-negative breast cancer (TNBC) is a heterogeneous disease characterized by the lack of estrogen receptor (ER), progesterone receptor (PR), and epidermal growth factor receptor 2 (HER2) and often associated with poor survival outcomes. The backbone of current treatments for TNBC relies on chemotherapy; however, resistance to cytotoxic agents is a commonly encountered hurdle to overcome. AREAS COVERED: Current understanding on the mechanisms involved in TNBC chemoresistance is evaluated and novel potential actionable targets and recently explored modalities for carrying and delivering chemotherapeutics are highlighted...
June 2022: Expert Opinion on Therapeutic Targets
https://read.qxmd.com/read/35715267/anti-mucin-4-fluorescent-antibody-brightly-targets-colon-cancer-in-patient-derived-orthotopic-xenograft-mouse-models-a-proof-of-concept-study-for-future-clinical-applications
#40
JOURNAL ARTICLE
Michael A Turner, Hannah M Hollandsworth, Siamak Amirfakhri, Thinzar M Lwin, Hiroto Nishino, Nicholas C Neel, Gopalakrishnan Natarajan, Sukhwinder Kaur, Kavita Mallya, Robert M Hoffman, Surinder K Batra, Michael Bouvet
BACKGROUND: There is a high rate of positive surgical margins with resection of liver metastases in colorectal cancer (CRC). The present study reports using a fluorescent anti-mucin 4 (MUC4) antibodies to label primary CRC and liver metastases to better visualize tumor margins in mouse models. METHODS: Western blotting for MUC4 protein expression of normal colon and CRC tumor lysates was performed. Orthotopic primary and liver metastatic CRC mouse models received anti-MUC4 antibody conjugated to IR800 (MUC4-IR800)...
October 2022: American Journal of Surgery
keyword
keyword
159915
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.